To read this full article you need to be subscribed to Newsline.
Sign in Sign up for a FREE subscriptionIGIS, CHA Bio Group to launch life science real estate platform JV
IGIS Asia Investment Management, the pan-Asian investment arm of IGIS Asset Management, South Korea's largest real estate investment manager, has formed a partnership with CHA Bio Group, one of the largest and oldest biopharma groups in South Korea with a vast global presence, to form a new Asia Pacific life sciences real estate investment platform.
The venture targets to provide best-in-class life sciences real estate for research and development (R&D), manufacturing, and other supporting services for a spectrum of companies ranging from biotechnology incubators to multinational pharmaceutical groups in the Asia Pacific region, including metropolitan cities in South Korea. The partnership will rely on IGIS's past track record of real estate transactions and CHA's expertise in the life sciences industry to gain first-mover advantage in providing life sciences real estate solutions in South Korea and overseas.
IGIS and CHA share the view of the venture's role as a c
